Kardigan Quarterly Balance Sheet
NASDAQ: KARDHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kardigan financial position
As of Jun 30, 2026, Kardigan reported total assets of $721.8 million against total liabilities of $106.3 million. Shareholders' equity stood at $615.5 million, or 85.3% of assets. The company held $384.0 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 8.72, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Kardigan balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q? 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Cash & Equivalents | 384.00M | — | 90.12M | — |
| Short-Term Investments | 213.59M | — | — | — |
| Total Current Assets | 610.16M | — | — | — |
| Property, Plant & Equipment | 7.57M | — | — | — |
| Intangible Assets | 26.42M | — | — | — |
| Long-Term Investments | 63.10M | — | — | — |
| Total Assets | 721.79M | — | — | — |
| Accounts Payable | 14.02M | — | — | — |
| Total Current Liabilities | 70.00M | — | — | — |
| Total Liabilities | 106.26M | — | — | — |
| Shareholders' Equity | 615.52M | -300.63M | -151.31M | -98.28M |
| Retained Earnings | -453.40M | — | — | — |
| Net Cash (Debt) | 597.60M | — | 90.12M | — |
| Shares Outstanding | 93.47M | — | — | — |
This table shows 4 quarterly periods of Kardigan's balance sheet, from Q2 2026 back to Q? 2025, across 14 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow KARD's reporting calendar. What is a balance sheet?